Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion.
暂无分享,去创建一个
G. Evan | T. Littlewood | S. Pelengaris | Michael Khan | G. Elia | G. Elia | M. Khan
[1] G. Evan,et al. A matter of life and cell death. , 1998, Science.
[2] O. Yanuka,et al. Involvement of Myc targets in c-myc and N-myc induced human tumors , 1998, Oncogene.
[3] J Downward,et al. Ras signalling and apoptosis. , 1998, Current opinion in genetics & development.
[4] R. Poulsom,et al. A robust method for isotopic riboprobe in situ hybridisation to localise mRNAs in routine pathology specimens. , 1998, European journal of histochemistry : EJH.
[5] V. D’Agati,et al. C-MYC–induced Apoptosis in Polycystic Kidney Disease Is Bcl-2 and p53 Independent , 1997, The Journal of experimental medicine.
[6] F M Watt,et al. c-Myc promotes differentiation of human epidermal stem cells. , 1997, Genes & development.
[7] Quinn Ag. Ultraviolet radiation and skin carcinogenesis. , 1997 .
[8] T G O'Brien,et al. Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin. , 1997, Cancer research.
[9] Asim Khwaja,et al. Matrix adhesion and Ras transformation both activate a phosphoinositide 3‐OH kinase and protein kinase B/Akt cellular survival pathway , 1997, The EMBO journal.
[10] Paul Martin,et al. Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.
[11] D. Hanahan,et al. Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice. , 1997, Cancer research.
[12] D. Hanahan,et al. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.
[13] R. Schwartz,et al. Premalignant keratinocytic neoplasms. , 1996, Journal of the American Academy of Dermatology.
[14] D. Hanahan,et al. Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis. , 1995, Oncogene.
[15] G. Prendergast,et al. c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. , 1995, Oncogene.
[16] T. McDonnell,et al. Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis. , 1995, Oncogene.
[17] G. Evan,et al. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. , 1995, Nucleic acids research.
[18] J. Gordon,et al. In vivo analysis of cadherin function in the mouse intestinal epithelium: essential roles in adhesion, maintenance of differentiation, and regulation of programmed cell death , 1995, The Journal of cell biology.
[19] N. Schreiber-Agus,et al. Contrasting roles for c‐Myc and L‐Myc in the regulation of cellular growth and differentiation in vivo. , 1995, The EMBO journal.
[20] J. Cleveland,et al. The role of ornithine decarboxylase in c-Myc-induced apoptosis. , 1995, Current topics in microbiology and immunology.
[21] J. Rees,et al. Genetic alterations in non-melanoma skin cancer. , 1994, The Journal of investigative dermatology.
[22] J. Cleveland,et al. Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis , 1994, Molecular and cellular biology.
[23] M. Horton,et al. Apoptosis induced by inhibition of intercellular contact , 1994, The Journal of cell biology.
[24] L. Larsson,et al. Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. , 1994, Oncogene.
[25] B. Amati,et al. Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. , 1994, Current opinion in genetics & development.
[26] R. DePinho,et al. Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer. , 1994, Seminars in cancer biology.
[27] R. Eisenman,et al. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. , 1993, Genes & development.
[28] J. Garlick,et al. Tissue- and stratum-specific expression of the human involucrin promoter in transgenic mice. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[29] J. Gerdes,et al. The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins , 1993, The Journal of cell biology.
[30] S. Yuspa,et al. The Suprabasal Expression of α6β4 Integrin Is Associated with a High Risk for Malignant Progression in Mouse Skin Carcinogenesis , 1993 .
[31] J L Cleveland,et al. The ornithine decarboxylase gene is a transcriptional target of c-Myc. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[32] C. Campbell,et al. p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin. , 1993, The Journal of investigative dermatology.
[33] G. Evan,et al. The role of c-myc in cell growth. , 1993, Current opinion in genetics & development.
[34] R. Brent,et al. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites , 1993, Cell.
[35] E. Fuchs. Genetic skin disorders of keratin. , 1992, The Journal of investigative dermatology.
[36] S. Garte,et al. Oncogene amplification detected by in situ hybridization in radiation-induced skin cancers in rats. , 1992, Radiation research.
[37] Gerard I. Evan,et al. Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.
[38] C. Péchoux,et al. c-myc and c-Ha-ras cellular oncogenes and human papillomaviruses in benign and malignant cutaneous lesions. , 1992, Journal of dermatological science.
[39] J. Cleveland,et al. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. , 1991, Oncogene.
[40] E. Fuchs,et al. Epidermal differentiation: the bare essentials , 1990, The Journal of cell biology.
[41] W. Brown,et al. Structure and polymorphism of human telomere-associated DNA , 1990, Cell.
[42] T. Sun,et al. Label-retaining cells reside in the bulge area of pilosebaceous unit: Implications for follicular stem cells, hair cycle, and skin carcinogenesis , 1990, Cell.
[43] Suárez Hg. Activated oncogenes in human tumors. , 1989 .
[44] Didier Picard,et al. Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells , 1989, Nature.
[45] R. Palmiter,et al. Oncogene-induced liver neoplasia in transgenic mice. , 1989, Oncogene.
[46] M. Rieger,et al. Identification of an orthologous mammalian cytokeratin gene. High degree of intron sequence conservation during evolution of human cytokeratin 10. , 1988, Journal of molecular biology.
[47] E. Fuchs,et al. Use of monospecific antisera and cRNA probes to localize the major changes in keratin expression during normal and abnormal epidermal differentiation , 1988, The Journal of cell biology.
[48] G. Rennie,et al. MALIGNANT TRANSFORMATION OF SOLAR KERATOSES TO SQUAMOUS CELL CARCINOMA , 1988, The Lancet.
[49] S. Garte,et al. Activation of c-myc and c-K-ras oncogenes in primary rat tumors induced by ionizing radiation. , 1987, Molecular and cellular biology.
[50] J. Moore,et al. A sensitive and quantitative enzyme-linked immunosorbence assay for the c-myc and N-myc oncoproteins. , 1987, Oncogene research.
[51] E. Fuchs,et al. Evidence for posttranscriptional regulation of the keratins expressed during hyperproliferation and malignant transformation in human epidermis , 1986, The Journal of cell biology.
[52] G K Lewis,et al. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product , 1985, Molecular and cellular biology.
[53] W. Idler,et al. Structure of a gene for the human epidermal 67-kDa keratin. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[54] T. Sun,et al. The 50- and 58-kdalton keratin classes as molecular markers for stratified squamous epithelia: cell culture studies , 1983, The Journal of cell biology.
[55] T. Sun,et al. Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies , 1982, The Journal of cell biology.
[56] T. Slaga,et al. alpha-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[57] F. J. Ensell,et al. ATMOSPHERIC OZONE AND FEMORAL FRACTURES , 1975, The Lancet.
[58] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.